Predictive biomarkers for dasatinib treatment in melanoma

Dasatinib has anti-proliferative and anti-invasive effects in melanoma cell lines. However clinical trials have shown modest activity for dasatinib in metastatic melanoma. Although dasatinib targets SRC kinase, neither expression nor phosphorylation of SRC appears to predict response to dasatinib. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Eustace, Alex J., Kennedy, Susan, Larkin, Anne-Marie, Mahgoub, Thamir, Tryfonopoulos, Dimitrios, O'Driscoll, Lorraine, Clynes, Martin, Crown, John, O'Donovan, Norma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278284/
https://www.ncbi.nlm.nih.gov/pubmed/25594008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278284/
https://www.ncbi.nlm.nih.gov/pubmed/25594008

Ejemplares similares